研究太极拳治糖尿病,福建中医药大学副校长获880万经费

2020-01-01 岳怀让 澎湃新闻

记者注意到,福建中医药大学官网12月27日发布消息《我校获批国家重点研发计划重点专项》透露:近日,我校陶静副校长主持的“太极拳对2型糖尿病及脑卒中功能康复效果的临床研究”获国家重点研发计划“中医药现代化研究”重点专项2019年度项目立项,资助经费880万元,实现我校在国家重点研发计划中“零”的突破。学校官网介绍:陶静,女,汉族,江苏淮安人,1977年2月出生,中共党员,研究生学历,医学博士,教授,

记者注意到,福建中医药大学官网12月27日发布消息《我校获批国家重点研发计划重点专项》透露:近日,我校陶静副校长主持的“太极拳对2型糖尿病及脑卒中功能康复效果的临床研究”获国家重点研发计划“中医药现代化研究”重点专项2019年度项目立项,资助经费880万元,实现我校在国家重点研发计划中“零”的突破。

学校官网介绍:陶静,女,汉族,江苏淮安人,1977年2月出生,中共党员,研究生学历,医学博士,教授,博士生导师。

陶静现任福建中医药大学副校长、国家中医药管理局中医康复研究中心副主任。中国康复医学会中西医结合专业委员会主任委员,中国医学装备康复医学分会常委兼秘书长。美国Thomas Jefferson大学、哈佛大学麻省总医院访问学者。福建省百千万人才工程人选。以第一完成人获福建省科技进步一等奖1项,福建省教学成果特等奖1项。

陶静从2010年6月起任福建中医药大学康复医学院副院长兼附属康复医院副院长,2012年9月起任福建中医药大学康复医学院院长兼康复医院副院长,2016年4月任福建中医药大学康复医学院院长,2018年9月起任福建中医药大学党委常委、副校长。

澎湃新闻记者还注意到,根据学校官网披露的消息,作为一家中医药专业领域高校,福建中医药大学进入12月以来已在学术领域有了不少成绩。

例如,12月6-8日,中国中西医结合学会第七次世界中西医结合大会暨2019年度中国中西医结合学会科学技术奖颁奖会在济南山东大厦召开。会议颁发了2019年度中国中西医结合学会科学技术奖、科普奖等奖项。

福建中医药大学方面透露:我校药学院林羽教授课题组的科研成果《闽台特色藤本类药材基础研究及转化应用》荣获二等奖;药学院吴水生教授课题组的科研成果《石杉碱甲高产菌株选育的基础研究》荣获三等奖。同时,药学院作为第二完成单位的科研成果《中药大品种片仔癀技术提升系统研究》荣获二等奖。

12月20日,福建中医药大学官网发布消息《我校一课题获国家重大新药创制科技重大专项立项》透露:近日,我校中西医结合学院蔡晶教授的课题“抗帕金森病肌强直中药6类新药苁蓉舒痉颗粒研制”成功申报国家重大新药创制科技重大专项项目,获国家科技部立项,课题资助经费245.51万元。该课题是我校首次获得科技部重大新药创制项目资助。

12月23日,福建中医药大学官网发布消息《我校一成果获高校科研优秀成果奖(科学技术)二等奖》透露:近日,国家教育部发布2019年度高等学校科学研究优秀成果奖(科学技术)授奖决定。我校李灿东教授的《身在中医——走进中医的世界》获科学技术二等奖,这是我校首次获得国家教育部科技进步奖奖项。

另外,本月早些时候福建中医药大学还召开国家自然科学基金、国家社会科学基金申报工作会议:12月5日上午,我校召开2020年度国家自然科学基金、国家社会科学基金项目申报工作会议。校党委副书记黄子杰教授,科研处相关负责同志,各学院(研究院)、各附属单位领导、科研秘书参加会议。会议由科研处陈军处长主持。
 
福建中医药大学方面透露:会上,陈军处长就学校2019年国家自然科学基金、国家社会科学基金的申报、中标情况进行了介绍与分析,并就2020年国家自然科学基金、国家社会科学基金项目申报的工作思路及相关工作安排进行了说明。

消息还提到:黄子杰副书记作了动员讲话。他强调,国家自然科学基金及国家社会科学基金项目的重要性;他希望,各单位要继续努力,挖掘潜力,提高申报数量和质量;他要求,各单位在有针对性地做好申报培训辅导工作,让科研人员找到写好申请书的“窍门”的同时,要在政策上予以保证,形成良好的科研风气;此外,各单位要高度重视,统一思想,同心协力,共同为广大科研人员申请基金做好服务和支撑保障工作。

学校官网介绍:福建中医药大学创建于1958年,是我国创办较早的高等中医药院校之一,两次入选福建省重点建设高校,是福建省“一流大学”建设高校。

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (6)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1632131, encodeId=9d701632131e7, content=<a href='/topic/show?id=34c74421593' target=_blank style='color:#2F92EE;'>#太极#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44215, encryptionId=34c74421593, topicName=太极)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec5221859655, createdName=steven_u9, createdTime=Sat Mar 21 18:09:00 CST 2020, time=2020-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741933, encodeId=f85a1e419339b, content=<a href='/topic/show?id=8f996203462' target=_blank style='color:#2F92EE;'>#校长#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62034, encryptionId=8f996203462, topicName=校长)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=320934995200, createdName=liao1631, createdTime=Thu Apr 09 10:09:00 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409966, encodeId=b7e31409966be, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri Jan 03 11:09:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1556344, encodeId=2036155634471, content=<a href='/topic/show?id=45d044216f5' target=_blank style='color:#2F92EE;'>#太极拳#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44216, encryptionId=45d044216f5, topicName=太极拳)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=542b14746023, createdName=lxg956, createdTime=Fri Jan 03 11:09:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1042910, encodeId=57d9104291023, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Wed Jan 01 23:09:00 CST 2020, time=2020-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049701, encodeId=daac1049e0138, content=中医中药,大多被人诋毁,不过梅斯里总是客观公正的, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=运动yd, createdTime=Wed Jan 01 23:09:00 CST 2020, time=2020-01-01, status=1, ipAttribution=)]
    2020-03-21 steven_u9
  2. [GetPortalCommentsPageByObjectIdResponse(id=1632131, encodeId=9d701632131e7, content=<a href='/topic/show?id=34c74421593' target=_blank style='color:#2F92EE;'>#太极#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44215, encryptionId=34c74421593, topicName=太极)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec5221859655, createdName=steven_u9, createdTime=Sat Mar 21 18:09:00 CST 2020, time=2020-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741933, encodeId=f85a1e419339b, content=<a href='/topic/show?id=8f996203462' target=_blank style='color:#2F92EE;'>#校长#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62034, encryptionId=8f996203462, topicName=校长)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=320934995200, createdName=liao1631, createdTime=Thu Apr 09 10:09:00 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409966, encodeId=b7e31409966be, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri Jan 03 11:09:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1556344, encodeId=2036155634471, content=<a href='/topic/show?id=45d044216f5' target=_blank style='color:#2F92EE;'>#太极拳#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44216, encryptionId=45d044216f5, topicName=太极拳)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=542b14746023, createdName=lxg956, createdTime=Fri Jan 03 11:09:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1042910, encodeId=57d9104291023, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Wed Jan 01 23:09:00 CST 2020, time=2020-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049701, encodeId=daac1049e0138, content=中医中药,大多被人诋毁,不过梅斯里总是客观公正的, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=运动yd, createdTime=Wed Jan 01 23:09:00 CST 2020, time=2020-01-01, status=1, ipAttribution=)]
    2020-04-09 liao1631
  3. [GetPortalCommentsPageByObjectIdResponse(id=1632131, encodeId=9d701632131e7, content=<a href='/topic/show?id=34c74421593' target=_blank style='color:#2F92EE;'>#太极#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44215, encryptionId=34c74421593, topicName=太极)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec5221859655, createdName=steven_u9, createdTime=Sat Mar 21 18:09:00 CST 2020, time=2020-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741933, encodeId=f85a1e419339b, content=<a href='/topic/show?id=8f996203462' target=_blank style='color:#2F92EE;'>#校长#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62034, encryptionId=8f996203462, topicName=校长)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=320934995200, createdName=liao1631, createdTime=Thu Apr 09 10:09:00 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409966, encodeId=b7e31409966be, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri Jan 03 11:09:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1556344, encodeId=2036155634471, content=<a href='/topic/show?id=45d044216f5' target=_blank style='color:#2F92EE;'>#太极拳#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44216, encryptionId=45d044216f5, topicName=太极拳)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=542b14746023, createdName=lxg956, createdTime=Fri Jan 03 11:09:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1042910, encodeId=57d9104291023, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Wed Jan 01 23:09:00 CST 2020, time=2020-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049701, encodeId=daac1049e0138, content=中医中药,大多被人诋毁,不过梅斯里总是客观公正的, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=运动yd, createdTime=Wed Jan 01 23:09:00 CST 2020, time=2020-01-01, status=1, ipAttribution=)]
    2020-01-03 cathymary
  4. [GetPortalCommentsPageByObjectIdResponse(id=1632131, encodeId=9d701632131e7, content=<a href='/topic/show?id=34c74421593' target=_blank style='color:#2F92EE;'>#太极#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44215, encryptionId=34c74421593, topicName=太极)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec5221859655, createdName=steven_u9, createdTime=Sat Mar 21 18:09:00 CST 2020, time=2020-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741933, encodeId=f85a1e419339b, content=<a href='/topic/show?id=8f996203462' target=_blank style='color:#2F92EE;'>#校长#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62034, encryptionId=8f996203462, topicName=校长)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=320934995200, createdName=liao1631, createdTime=Thu Apr 09 10:09:00 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409966, encodeId=b7e31409966be, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri Jan 03 11:09:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1556344, encodeId=2036155634471, content=<a href='/topic/show?id=45d044216f5' target=_blank style='color:#2F92EE;'>#太极拳#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44216, encryptionId=45d044216f5, topicName=太极拳)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=542b14746023, createdName=lxg956, createdTime=Fri Jan 03 11:09:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1042910, encodeId=57d9104291023, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Wed Jan 01 23:09:00 CST 2020, time=2020-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049701, encodeId=daac1049e0138, content=中医中药,大多被人诋毁,不过梅斯里总是客观公正的, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=运动yd, createdTime=Wed Jan 01 23:09:00 CST 2020, time=2020-01-01, status=1, ipAttribution=)]
    2020-01-03 lxg956
  5. [GetPortalCommentsPageByObjectIdResponse(id=1632131, encodeId=9d701632131e7, content=<a href='/topic/show?id=34c74421593' target=_blank style='color:#2F92EE;'>#太极#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44215, encryptionId=34c74421593, topicName=太极)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec5221859655, createdName=steven_u9, createdTime=Sat Mar 21 18:09:00 CST 2020, time=2020-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741933, encodeId=f85a1e419339b, content=<a href='/topic/show?id=8f996203462' target=_blank style='color:#2F92EE;'>#校长#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62034, encryptionId=8f996203462, topicName=校长)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=320934995200, createdName=liao1631, createdTime=Thu Apr 09 10:09:00 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409966, encodeId=b7e31409966be, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri Jan 03 11:09:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1556344, encodeId=2036155634471, content=<a href='/topic/show?id=45d044216f5' target=_blank style='color:#2F92EE;'>#太极拳#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44216, encryptionId=45d044216f5, topicName=太极拳)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=542b14746023, createdName=lxg956, createdTime=Fri Jan 03 11:09:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1042910, encodeId=57d9104291023, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Wed Jan 01 23:09:00 CST 2020, time=2020-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049701, encodeId=daac1049e0138, content=中医中药,大多被人诋毁,不过梅斯里总是客观公正的, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=运动yd, createdTime=Wed Jan 01 23:09:00 CST 2020, time=2020-01-01, status=1, ipAttribution=)]
    2020-01-01 misszhang

    谢谢MedSci提供最新的资讯

    0

  6. [GetPortalCommentsPageByObjectIdResponse(id=1632131, encodeId=9d701632131e7, content=<a href='/topic/show?id=34c74421593' target=_blank style='color:#2F92EE;'>#太极#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=39, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44215, encryptionId=34c74421593, topicName=太极)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=ec5221859655, createdName=steven_u9, createdTime=Sat Mar 21 18:09:00 CST 2020, time=2020-03-21, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1741933, encodeId=f85a1e419339b, content=<a href='/topic/show?id=8f996203462' target=_blank style='color:#2F92EE;'>#校长#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=28, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=62034, encryptionId=8f996203462, topicName=校长)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=320934995200, createdName=liao1631, createdTime=Thu Apr 09 10:09:00 CST 2020, time=2020-04-09, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1409966, encodeId=b7e31409966be, content=<a href='/topic/show?id=2c1c35262a9' target=_blank style='color:#2F92EE;'>#医药#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=31, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=35262, encryptionId=2c1c35262a9, topicName=医药)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=36f62754598, createdName=cathymary, createdTime=Fri Jan 03 11:09:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1556344, encodeId=2036155634471, content=<a href='/topic/show?id=45d044216f5' target=_blank style='color:#2F92EE;'>#太极拳#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=0, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=44216, encryptionId=45d044216f5, topicName=太极拳)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=542b14746023, createdName=lxg956, createdTime=Fri Jan 03 11:09:00 CST 2020, time=2020-01-03, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1042910, encodeId=57d9104291023, content=谢谢MedSci提供最新的资讯, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=misszhang, createdTime=Wed Jan 01 23:09:00 CST 2020, time=2020-01-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1049701, encodeId=daac1049e0138, content=中医中药,大多被人诋毁,不过梅斯里总是客观公正的, beContent=null, objectType=article, channel=null, level=null, likeNumber=53, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=f0620, createdName=运动yd, createdTime=Wed Jan 01 23:09:00 CST 2020, time=2020-01-01, status=1, ipAttribution=)]
    2020-01-01 运动yd

    中医中药,大多被人诋毁,不过梅斯里总是客观公正的

    0

相关资讯

Diabetologia:胰岛素原肽可促进自身免疫性糖尿病?

最近对儿童的自然史研究表明,特定的HLA基因型与免疫反应的第一个抗原靶点之间存在联系。然而目前,关于特异性HLA分子对1型糖尿病等自身免疫性疾病病理影响的分子基础尚不清楚。本研究以一种常见的糖尿病相关HLA单倍型为背景,通过探讨胰岛抗原的致糖尿病性来研究这种体内联系。

Diabetes:二型糖尿病,原来是非酯化游离脂肪酸惹的祸?

一项刊发于美国《Diabetes》杂志的新研究提出了一种专门调节胰岛中非葡萄糖刺激的胰岛素分泌(NGSIS)的机制,该机制由非酯化的游离脂肪酸(禁食期间β细胞利用的主要燃料)激活。

PNAS:阻断钙通道有望成为治疗糖尿病的新策略!

近日,瑞典Karolinska学院的研究人员发现并鉴定了一种钙通道——CaV3.1通道,它的过度激活会抑制胰岛素的释放,干扰葡萄糖稳态,进而导致糖尿病。这项研究发表在科学期刊PNAS上。

Diabetologia:短期力量和平衡训练并不能改善生活质量,但可以改善糖尿病周围神经病变患者的功能状态?

本研究的目的是测试结构性力量和平衡训练干预对改善糖尿病周围神经病变(DPN)患者健康相关生活质量(HRQoL)和功能状态的有效性。

Lancet Diabetes Endo:胰岛素抵抗、β细胞功能障碍、肥胖对中国糖尿病风险的影响

研究发现,在中国成年人中,胰岛素抵抗比β-细胞功能障碍更容易导致糖尿病,在肥胖人群中更为明显

2020 ADA 糖尿病医学诊疗标准

ADA制定的《糖尿病医学诊疗标准》是指导糖尿病医生临床实践的重要指南之一,每年都会对该指南进行更新和修改。2020年美国糖尿病学会(ADA)糖尿病医学诊疗标准发布,共包括16部分内容。